Nuveen Asset Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$30.4M Sell
1,743,190
-88,913
-5% -$1.55M 0.01% 908
2024
Q3
$25.6M Buy
1,832,103
+1,094,465
+148% +$15.3M 0.01% 1020
2024
Q2
$6.06M Buy
737,638
+6,260
+0.9% +$51.5K ﹤0.01% 1848
2024
Q1
$5.64M Buy
731,378
+247,050
+51% +$1.9M ﹤0.01% 1928
2023
Q4
$4.35M Sell
484,328
-220,975
-31% -$1.99M ﹤0.01% 2059
2023
Q3
$6.31M Sell
705,303
-185,474
-21% -$1.66M ﹤0.01% 1748
2023
Q2
$13.7M Buy
890,777
+563,124
+172% +$8.65M ﹤0.01% 1311
2023
Q1
$7.37M Buy
327,653
+143,585
+78% +$3.23M ﹤0.01% 1662
2022
Q4
$4.54M Sell
184,068
-225,420
-55% -$5.56M ﹤0.01% 1968
2022
Q3
$10.1M Sell
409,488
-27,469
-6% -$677K ﹤0.01% 1467
2022
Q2
$10.8M Buy
436,957
+28,988
+7% +$715K ﹤0.01% 1453
2022
Q1
$10.1M Sell
407,969
-9,855
-2% -$243K ﹤0.01% 1634
2021
Q4
$10.3M Sell
417,824
-58,721
-12% -$1.45M ﹤0.01% 1671
2021
Q3
$11.8M Sell
476,545
-196,772
-29% -$4.85M ﹤0.01% 1667
2021
Q2
$16.6M Sell
673,317
-193,909
-22% -$4.78M ﹤0.01% 1512
2021
Q1
$21.4M Buy
867,226
+106,204
+14% +$2.62M 0.01% 1268
2020
Q4
$18.8M Buy
761,022
+44,871
+6% +$1.11M 0.01% 1304
2020
Q3
$13.2M Buy
716,151
+120,618
+20% +$2.23M 0.01% 1333
2020
Q2
$12.2M Buy
595,533
+34,000
+6% +$694K ﹤0.01% 1356
2020
Q1
$8.19M Buy
561,533
+4,547
+0.8% +$66.3K ﹤0.01% 1418
2019
Q4
$7.91M Sell
556,986
-16,089
-3% -$228K ﹤0.01% 1730
2019
Q3
$6.64M Sell
573,075
-137,386
-19% -$1.59M ﹤0.01% 1803
2019
Q2
$14.3M Buy
+710,461
New +$14.3M 0.01% 1378